Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myeloid Leukemia (CML-BP)”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)UnknownNCT01690065
What this trial is testing

Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML

Who this might be right for
Chronic Myeloid Leukemia in Myeloid Blast CrisisUntreated Adult Acute Myeloid Leukemia
Ulsan University Hospital 46
Not applicableEnded earlyNCT02455024
What this trial is testing

An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®

Who this might be right for
Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
Ariad Pharmaceuticals 3
Post-approval studies (Phase 4)Looking for participantsNCT04877522
What this trial is testing

Asciminib Roll-over Study

Who this might be right for
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals 347
Early research (Phase 1)Study completedNCT00003997
What this trial is testing

6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)UnknownNCT02511340
What this trial is testing

A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients

Who this might be right for
Chronic Myelogenous Leukemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 167
Early research (Phase 1)Ended earlyNCT00664677
What this trial is testing

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Who this might be right for
LeukemiasAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)+5 more
Erimos Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00548847
What this trial is testing

Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

Who this might be right for
Leukemia
Emory University 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07259161
What this trial is testing

Modified Conditioning Regimen for CML-BP

Who this might be right for
CML,Blast PhaseHSCT
Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)Study completedNCT00088231
What this trial is testing

PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP

Who this might be right for
Acute Myelogenous LeukemiaAgnogenic Myeloid MetaplasiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408
What this trial is testing

Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more
The University of Hong Kong
Early research (Phase 1)Ended earlyNCT02225574
What this trial is testing

An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT05433532
What this trial is testing

Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients

Who this might be right for
Philadelphia ChromosomeAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+2 more
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT00042003
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
45